To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: PBX homeobox 1 (PBX1); Janus kinase-1 (JAK-1); JAK-2

Cancer

INDICATION: Ovarian cancer

Patient sample, cell culture and mouse studies suggest inhibiting PBX1 or JAK-2 could help treat

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE